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Abstract
Background: Clonal microbial populations often harbor rare phenotypic variants that are typically hidden within
the majority of the remaining cells, but are crucial for the population’s resilience to external perturbations. Persister
and viable but non-culturable (VBNC) cells are two important clonal bacterial subpopulations that can survive
antibiotic treatment. Both persister and VBNC cells pose a serious threat to human health. However, unlike persister
cells, which quickly resume growth following drug removal, VBNC cells can remain non-growing for prolonged
periods of time, thus eluding detection via traditional microbiological assays. Therefore, understanding the
molecular mechanisms underlying the formation of VBNC cells requires the characterization of the clonal
population with single-cell resolution. A combination of microfluidics, time-lapse microscopy, and fluorescent
reporter strains offers the perfect platform for investigating individual cells while manipulating their environment.
Methods: Here, we report a novel single-cell approach to investigate VBNC cells. We perform drug treatment,
bacterial culturing, and live/dead staining in series by using transcriptional reporter strains and novel adaptations to
the mother machine technology. Since we track each cell throughout the experiment, we are able to quantify the
size, morphology and fluorescence that each VBNC cell displayed before, during and after drug treatment.
Results: We show that VBNC cells are not dead or dying cells but share similar phenotypic features with persister
cells, suggesting a link between these two subpopulations, at least in the Escherichia coli strain under investigation.
We strengthen this link by demonstrating that, before drug treatment, both persister and VBNC cells can be
distinguished from the remainder of the population by their lower fluorescence when using a reporter strain for
tnaC, encoding the leader peptide of the tnaCAB operon responsible for tryptophan metabolism.
Conclusion: Our data demonstrates the suitability of our approach for studying the physiology of non-growing
cells in response to external perturbations. Our approach will allow the identification of novel biomarkers for the
isolation of VBNC and persister cells and will open new opportunities to map the detailed biochemical makeup of
these clonal subpopulations.
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Background
Clonal bacterial populations show cell-to-cell differences
in physiological parameters, including responses to exter-
nal perturbations [1]. For example, under drug treatment,
the majority of a clonal bacterial population is susceptible
to the drug, whereas at least two subpopulations – per-
sister cells and viable but non-culturable (VBNC) cells –
are able to survive high doses of antibiotics. Persister cells
survive the antibiotic challenge and resume growth on
nutrient-rich media shortly after removing the drug [2, 3],
whereas VBNC cells survive the antibiotic challenge but
may regrow only after a long and specific treatment [4].
Therefore, VBNC cells are difficult to detect and study via
standard microbiology assays.
Persister and VBNC cells are in a transient state and
are often, but not always [5], associated with dormancy
[2, 6]. It has been suggested that they form stochastically
as a result of fluctuations in gene and protein expression
[6, 7]. However, deterministic components of persister
and VBNC formation have also been documented [8–13].
Persister and VBNC cells pose a serious threat to human
health since they may be recalcitrant to drug treatment
[2], and thus can contribute to the relapse of diseases such
as tuberculosis, cystic fibrosis-associated lung infections,
candidiasis, cholera, septicemia, and gastroenteritis [4].
Furthermore, these subpopulations may constitute a
reservoir for the development of antibiotic resistance
mechanisms [14].
The recent advances in single-cell microfluidic analysis
[15] have greatly enriched our understanding of persister
cells, highlighting the contributions from toxin-antitoxin
modules [6], the alarmone guanosine tetraphosphate
pathway [7, 16, 17], efflux activity [18], the catalase-
peroxidase enzyme [19], respiration [20], and protein
production [21, 22]. However, single-cell microfluidic
analysis has not yet been implemented to investigate
VBNC cells due to the difficulty in distinguishing these
cells from dead or dying cells, and the requirement to
image and track thousands of individual cells. Neverthe-
less, VBNC cells constitute a major public health con-
cern, since they have been observed in 51 human
pathogens [3] and are difficult to eradicate via standard
sterilization treatments such as heat, acid, ethanol, anti-
biotic or osmotic stress [23]. Therefore, there is an ur-
gent to develop methodologies to study and combat
bacteria in the VBNC state [4].
Here, we introduce a novel single-cell approach allowing,
for the first time, the investigation of the changes in size,
morphology and promoter activity in VBNC cells respond-
ing to drug treatment (Fig. 1). We take advantage of the
well-established mother machine device [24, 25], designed
to investigate the growth of a large number of individual E.
coli cells. This device is equipped with thousands of micro-
fluidic channels with cross section comparable to the size
of individual E. coli cells and connected to a large micro-
fluidic chamber where the medium is continuously ex-
changed via pressure-driven microfluidics. In this paper,
we use this technology to perform drug treatment, bacter-
ial culturing, and live/dead staining in series, while imaging
and tracking individual cells, thus permitting the iden-
tification of single VBNC cells alongside persister or
susceptible cells. This new methodology allows us to
obtain the following crucial information that will advance
our understanding of VBNC cells. (1) We demonstrate
that ampicillin-treated stationary phase E. coli cultures
contain more VBNC than persister cells. (2) We show
that, before drug treatment, VBNC cells exhibit cell length
and levels of fluorescence for selected reporter strains
similar to the ones measured in persister cells, supporting
the hypothesis that these two phenotypes are part of a
shared physiological continuum at least in the investigated
E. coli strain [4]. (3) We demonstrate that, after drug treat-
ment, VBNC cells are distinct from dead or dying cells
and display fluorescence levels comparable to persister
cells. (4) We identify the fluorescence of the tnaC reporter
strain as a new biomarker for distinguishing persister and
VBNC bacteria from the remainder of the population be-
fore drug treatment. Our novel single-cell approach will
facilitate unraveling the molecular mechanisms underlying
the formation of non-growing subpopulations and
their capabilities to survive environmental changes.
As such, our methodology represents a powerful tool
for researchers investigating phenotypic or genotypic
heterogeneity.
Results
Identification of VBNC cells
We chose to apply our novel single-cell approach to
stationary phase E. coli cultures because the fraction of
VBNC and persister cells in this growth phase is in the
range 10-3–10-1 [18, 20, 26, 27]. This suggested that
these phenotypes could be investigated with our pro-
posed approach since it allows manipulating and track-
ing of approximately 2000 individual cells. In order to
do so, we first loaded a 2-μL aliquot of a stationary
phase E. coli culture into the microfluidic mother ma-
chine device [24] and confined the bacteria in the lateral
channels of the device (t = 0, Fig. 1a, e). We then treated
the bacteria with a high dose of ampicillin, 25× minimum
inhibitory concentration (MIC), dissolved in Lysogeny
broth (LB; 0 < t < 3 h, Fig. 1b). Since ampicillin targets cell
wall synthesis, we identified susceptible lysed cells that die
and lyse either during or after drug treatment and com-
prise the majority of the population (leftmost channel
in Fig. 1) [28]. We then exchanged the drug-containing
medium for LB (3 < t < 24 h, Fig. 1c) and identified in-
tact persister cells that survived the antibiotic challenge
and could regrow upon restoring favorable conditions
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(third channel from the left in Fig. 1), similarly to previ-
ously reported microfluidic approaches [6, 7, 18, 19].
However, these methodologies did not allow the study
of VBNC cells. In order to overcome this limitation, we
performed live/dead staining as a last step in the series
of our on-chip assays [5, 29, 30]. This step allowed us
to identify two further phenotypes of susceptible non-
lysed cells that died but did not lyse during nor after
drug treatment (rightmost channel in Fig. 1) and VBNC
cells that survived the antibiotic challenge but did not
regrow upon restoring favorable conditions (second
channel from the left in Fig. 1). Since we imaged and
tracked each single cell throughout this series of assays,
we were able to measure the size and morphology of
each single cell before, during and after drug treatment
and to assign each cell to a specific phenotype at the
end of the experiment. This is, to the best of our know-
ledge, the first methodology allowing for the study of
VBNC cells, alongside persister and susceptible cells,
before, during, and after drug treatment.
Size and morphology of VBNC cells before, during, and
after ampicillin treatment
Before ampicillin treatment (t = 0), the four phenotypes
(persister, VBNC, susceptible lysed, and susceptible non-
lysed cells) had similar average lengths (Fig. 2a), calcu-
lated as the mean and standard error of the mean of
single-cell measurements for the different phenotypes.
Persister cells survived the 3-h ampicillin treatment and
began dividing within 2 hours of exposure to LB
(Additional file 1: Figure S1a); forming microcolonies
and reaching an average length of 3.8 ± 0.2 μm by t =
24 h. In contrast, after exposure to ampicillin and
subsequent incubation in LB, VBNC cells were smaller
(2.3 ± 0.2 μm) in average length, (squares in Fig. 2a) and
more rounded compared to persister cells. Indeed, both
cell dwarfing and rounding have been observed in VBNC
cells of many species [31, 32]. In separate control ex-
periments we measured the growth of bacteria con-
fined in the lateral channels of the mother machine
device and exposed to LB, but without the addition of
Fig. 1 Single-cell approach to study viable but non-culturable (VBNC) cells. Schematic illustrating the steps carried out to distinguish VBNC
cells from susceptible non-lysed (SNL), susceptible lysed (SL), and persister (P) cells. a A 2-μL aliquot of a stationary phase E. coli BW25113
culture was loaded in the lateral channels of the mother machine device. b Between t = 0 and t = 3 h, ampicillin was injected in the
mother machine device at a concentration of 25 × the minimum inhibitory concentration in Lysogeny broth (LB) progressively lysing the
majority of bacteria (SL cells, leftmost channel). c Between t = 3 and t = 24 h, LB was injected in the microfluidic device, P bacteria started
to grow and eventually gave rise to progeny (third channel from the left). d At t = 24 h, a live/dead staining assay was performed by
flowing in the microfluidic device SYTO9 and propidium iodide, distinguishing VBNC bacteria staining green (second channel from the left) from SNL
bacteria staining red (rightmost channel). Representative bright-field (e–f) and fluorescence images (g) of the four phenotypes illustrated above, before
(e) and after (f, g) drug treatment. The weak red staining in the channel containing the SL bacterium was due to cell debris barely visible in the
corresponding bright-field image. Scale bar, 5 μm
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ampicillin (Additional file 1: Figure S1b, c). As ex-
pected, these bacteria exhibited similar initial average
length to the bacteria measured in the ampicillin
treatment experiments. However, they began dividing
within 2 hours of exposure to LB (Additional file 1:
Figure S1b) and at t = 24 h exhibited an average
length close to that measured for the persister cell
progenies (diamonds in Additional file 1: Figure S1c).
VBNC cells constitute the majority of cells surviving
ampicillin treatment in a stationary phase E. coli culture
We enumerated the bacteria belonging to the four pheno-
types and defined fSL, fSNL, fP, and fVBNC as the fractions
given by the number of counts for susceptible lysed, sus-
ceptible non-lysed, persister, or VBNC cells, respectively,
divided by the number of total cells imaged in our assay
before drug treatment. When we used a high dose of
ampicillin (25 ×MIC), we measured fVBNC = 0.01 and fP =
0.003 (Fig. 2b). Therefore, we provide direct evidence that
VBNC cells, rather than persister cells as recently reported
[18], constitute the majority of cells surviving ampicillin
treatment in a stationary phase E. coli culture [27]. These
cells possibly entered the VBNC state during nutrient star-
vation in stationary phase [32] or during the successive
antibiotic treatment [23]. These findings suggest the need
for investigating the VBNC phenotype in concert with
persister cells [4]. We also found that susceptible cells that
did not lyse were another small fraction, while the ma-
jority of bacteria lysed as a result of drug treatment
(fSNL = 0.047 and fSL = 0.94, Fig. 2c and d, respectively).
Fig. 2 Dimension and fraction of viable but non-culturable (VBNC)
cells. a Average length of VBNC cells (green squares), alongside
persister (blue circles), susceptible non-lysed (black upward triangles),
and susceptible lysed cells (red downward triangles) before (t = 0),
during (0 < t < 3 h), and after treatment (3 < t < 24 h) with ampicillin at
a concentration of 25 ×minimum inhibitory concentration in Lysogeny
broth. We assigned a length value of zero to cells that became
undetectable with our code upon cell lysis. This explains the
decrease in the average length of susceptible lysed cells. Lengths
of untreated cells in control experiments are reported in Additional
file 1: Figure S1a. Bacterial width did not significantly change
throughout the experiment for the different phenotypes but for
susceptible lysed cells (data not shown). Data and error bars are
mean and standard error of the mean obtained by averaging single-
cell values (nSL= 1651, nP = 33, nVBNC= 48, nSNL = 87) measured in the
microfluidic experiment illustrated in Fig. 1 performed on biological
triplicates (N = 3). We did not observe any significant difference
between the results obtained from different biological replica. Due to
the large sample sizes, error bars are small compared to the
corresponding mean values and are hidden behind some of the
data points. Ampicillin concentration dependence of the fraction
of (b) VBNC and persister cells surviving the antibiotic challenge,
of (c) susceptible non-lysed cells, and of (d) susceptible lysed
cells killed by the antibiotic challenge. Data and error bars are
obtained by averaging each phenotype frequency measured at
least in biological triplicate
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We confirmed the reliability of our assay by performing
bulk ampicillin treatment and colony forming unit (CFU)
assays on separate aliquots of the same E. coli cultures.
Through these bulk assays we obtained a measured fP
similar to that measured via our novel single-cell assay
(Additional file 2: Figure S2) and to previously reported fP
values [33]. The CFU method does not, however, allow
distinction between the VBNC and susceptible pheno-
types. In contrast, our novel methodology provides a
powerful tool to identify and study VBNC cells. Moreover,
we found that fP and fVBNC decreased with ampicillin con-
centration (Fig. 2b and Additional file 2: Figure S2),
whereas fSNL and fSL increased (Fig. 2c, d). It is worth not-
ing that, at high ampicillin concentration (25 ×MIC) we
measured four times as many VBNC as persister cells,
whereas at a lower ampicillin concentration (12.5 ×MIC)
this ratio was reversed, with fP being three times
higher than fVBNC (Fig. 2b). These findings suggest the
importance of employing the same standardized dose
of drug when studying rare phenotypes within a clonal
population.
Tracking promoter activity in individual VBNC cells
In order to further investigate the VBNC state, we used
the approach illustrated in Fig. 1 in combination with
green fluorescent protein (GFP) transcriptional reporter
strains [34]. Each strain carried a low copy number plas-
mid with the promoter region of a gene of interest
inserted upstream of a gene for a fast-folding GFP with
an average lifetime of 8 h. GFP expression levels in indi-
vidual strains of this library have been used to measure
the corresponding promoter activity both at the popula-
tion and single cell levels [34, 35]. We used this ap-
proach to measure single-cell GFP fluorescence levels as
a proxy for the activity of the promoters that initiate the
transcription of the genes tolC, tnaC, and ptsG. The tolC
gene encodes part of the multidrug efflux pump AcrAB-
TolC, and E. coli persister cells have previously been
shown to exhibit higher tolC expression than untreated
cells [18]. The tnaC gene encodes the leader peptide of
the tnaCAB operon responsible for tryptophan transport
and catabolism, including the enzyme TnaA, which
converts tryptophan to indole, pyruvate, and ammonia.
Indole has previously been shown to regulate the forma-
tion of E. coli persister cells [9, 36]. The role of these
putative persister genes in VBNC cells remains to be in-
vestigated. The ptsG gene encodes part of the glucose
permease transporter, and was chosen as a control gene
as it has not been previously associated with persister
nor with VBNC cells.
Figure 3a–c shows a representative set of images dis-
playing GFP fluorescence of a persister cell, a VBNC cell
(dashed and dotted contours, respectively), and five sus-
ceptible lysed cells of the tolC reporter strain. Figure 3d–g
shows the corresponding single-cell fluorescence through-
out the different steps of the experiment, which are before
(t = 0), during (0 < t < 3 h), and after (3 < t < 24 h) ampicil-
lin treatment. We found that the VBNC cell exhibited a
level of GFP fluorescence similar to the persister cell be-
fore and during drug treatment. After drug removal and
21 h exposure to LB, the VBNC cell was distinguishable
from susceptible lysed or susceptible non-lysed cells even
before performing the live/dead staining. In fact, whereas
susceptible cells did not show any GFP fluorescence, the
VBNC cell exhibited a high level of GFP fluorescence,
being more than two times brighter than the persister cell
progeny. This suggests that the non-growing VBNC
phenotype maintains an active tolC promoter.
We also found that susceptible non-lysed and susceptible
lysed cells showed similar patterns of fluorescence for the
three investigated reporter strains and henceforth refer to
them as susceptible cells. However, we identified two fur-
ther subgroups within the susceptible subpopulation in the
tolC reporter strain, namely cells that displayed increasing
fluorescence levels during drug treatment (filled triangles
in Fig. 3a–c, f and Additional file 3: Figure S3b) and cells
that showed decreasing levels of fluorescence (open trian-
gles in Fig. 3a–c, g and Additional file 3: Figure S3b).
VBNC cells can be distinguished from susceptible cells
before antibiotic treatment
In order to investigate the patterns of GFP fluorescence
in VBNC cells of the three reporter strains, we imaged,
tracked, and analyzed approximately 2000 individual
bacteria for each reporter strain.
Before ampicillin treatment, VBNC cells exhibited fluor-
escence levels similar to those measured in persister cells
for all the investigated reporter strains (Fig. 4a–c). This
further supports the hypothesis that the persister and
VBNC phenotypes are part of a shared physiological con-
tinuum [4]. Furthermore, persister and VBNC cells of the
tolC reporter strain exhibited only slightly higher fluores-
cence levels than susceptible cells (Fig. 4a). This suggests
that persister and VBNC cells may not rely on antibiotic
efflux to survive the antibiotic challenge in disagreement
with previously reported findings [18]. This disagreement,
however, could also be ascribed to the use of different
antibiotic treatment conditions. Remarkably, fluorescence
levels in persister and VBNC cells in the tnaC reporter
strain were half of those measured in susceptible cells,
possibly because the former are in a less active metabolic
state [27]. This contradicts a previous study that suggested
that persister cells exhibit higher levels of tnaC promoter
activity with respect to susceptible cells [9]; however, in
that study, 0.5 mM indole had been added to an exponen-
tially growing E. coli culture. Furthermore, a different
study suggested a link between reduction of tnaCAB op-
eron expression and the formation of persister cells [36],
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corroborating our findings. Our data suggests that the
persister and VBNC cells found in a stationary phase E.
coli culture constitute subpopulations existing before
exposure to ampicillin, confirming previous findings [6].
However, this is still under debate since other studies sug-
gest that exposure to antibiotics itself underlies persister
cell formation [12]. We anticipate that our new method-
ology will be crucial for identifying further phenotypic
differences between VBNC, persister, and susceptible cells
prior to drug treatment.
During ampicillin treatment, VBNC and persister
cells maintained similar fluorescence levels in the tolC
and tnaC reporter strains, but VBNC cells displayed
lower fluorescence levels in the ptsG reporter strain
compared to persister cells (circles and squares in
Fig. 4d–f, 0 < t < 3 h). On the contrary, susceptible
cells very quickly lost their fluorescence in all three
employed reporter strains (triangles in Fig. 4d–f ) but
not in a subpopulation of the tolC reporter strain
(Fig. 4d and Additional file 3: Figure S3).
Fig. 3 GFP fluorescence patterns in single viable but non-culturable (VBNC) cells. Fluorescence images reporting GFP expression levels, as a proxy for the
activity of the promoter of tolC, in a single VBNC cell (green square), alongside a persister cell (blue circle) and five susceptible cells (a) before, (b) during,
and (c) after drug treatment. Scale bar, 5 μm. Corresponding fluorescence patterns for the (d) persister, (e) VBNC, and (f, g) the two selected susceptible
cells in the images above. The VBNC cell exhibited a fluorescence pattern similar to the one of the persister cell throughout the entire assay, but the VBNC
cell was much brighter and easily distinguishable at t= 24 h. This suggests that the fluorescence associated to the tolC reporter strain could be used to
isolate VBNC cells from the remainder of the population after ampicillin treatment and 21 h exposure to LB. The two susceptible cells displayed very
different responses to the antibiotic treatment. For the cell in (f) (marked with a filled triangle in Fig. 3a), fluorescence levels increased during and
immediately after drug treatment but decreased after t= 5 h, with the cell eventually lysing by t= 24 h. For the cell in (g) (marked with an open
triangle in Fig. 3a), fluorescence levels decreased during drug treatment, with the cell lysing by t= 3 h. This suggests that besides the four phenotypes
introduced in Figs. 1 and 2, there are at least two further subgroups of susceptible cells (Additional file 3: Figure S3)
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After ampicillin treatment and 21 h exposure to LB,
VBNC cells displayed markedly different fluorescence
levels for all the investigated strains compared to persister
cells. VBNC cells maintained higher fluorescence levels in
the tolC and tnaC reporter strains, and exhibited different
fluorescence levels with respect to susceptible cells
(Additional file 4: Figure S4). This is consistent with
the hypothesis that, whereas dead cells do not express
genes, VBNC cells continue producing mRNA [37].
Therefore, we unambiguously demonstrated that VBNC
cells can be distinguished from susceptible non-lysed
cells before, during, and after drug treatment. Persister
cells instead showed higher fluorescence levels in the
ptsG reporter strain (Fig. 4g–i) compared to VBNC
cells, suggesting that the former were utilizing a higher
amount of sugars after drug treatment.
In separate control experiments we measured the
changes in GFP fluorescence of bacteria confined in the lat-
eral channels of the mother machine device, exposing them
to LB without the addition of ampicillin. As expected, these
bacteria exhibited similar fluorescence levels to susceptible
cells at t = 0 (Additional file 5: Figure S5). Moreover, during
exposure to LB, these bacteria exhibited similar pat-
terns of fluorescence levels as persister cells (Additional
file 6: Figure S6, 3 < t < 24 h), further suggesting that
persister cells had reverted to a normally growing state.
Fig. 4 Distribution of GFP fluorescence levels in viable but non-culturable (VBNC) cells before and after drug treatment. Distribution of fluorescence levels
in VBNC (green) cells, alongside the susceptible (red) and persister (blue) phenotypes in the (a) tolC, (b) tnaC, and (c) ptsG reporter strains before drug
treatment (t = 0). Susceptible cells include both susceptible lysed and susceptible non-lysed phenotypes since these exhibit similar GFP fluorescence
patterns. d–f Corresponding average pattern of fluorescence levels for the different phenotypes and reporter strains throughout the microfluidic assay,
0 < t< 24 h. g–i Distributions of fluorescence levels after drug removal and 21 h exposure to LB. The bottom and top of the box are the first and third
quartiles, the band inside the box is the median, the bottom and top whiskers represent the 10th and 90th percentiles, respectively. Data are obtained at
least in biological triplicate (N= 3) for each reporter strain employed for a total of nS= 6659, nP = 198, and nVBNC = 147 fluorescence patterns of single
susceptible, persister, and VBNC cells, respectively. We did not observe any significant difference between the results obtained from different biological
replica. Due to the large sample sizes, error bars are small compared to the corresponding mean values and are hidden behind some of the data points
in (d), (e) and (f). The differential tnaC fluorescence levels in VBNC cells with respect to susceptible cells allows identifying the former as the dimmest
cells before drug treatment, establishing tnaC-GFP as a potential biomarker to isolate VBNC cells, alongside persister cells, within the
untreated clonal population. Moreover, at t = 24 h, VBNC cells display increased fluorescence levels in the tolC and tnaC reporter strains,
whereas persister cells show increased fluorescence levels in the ptsG reporter strain. Therefore, the three investigated reporter strains
could be used in future as biomarkers to distinguish and isolate VBNC from persister cells after drug challenge and exposure to LB,
these two phenotypes often being confused
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Discussion
Progress in our understanding of VBNC cells since
their discovery in 1982 [38] has been slow and incre-
mental. Our approach represents a general tool to
measure the physiological state of VBNC cells,
alongside persister cells, before antibiotic treatment.
Moreover, this approach, as well as other recently
introduced methods [27], can serve to bridge the gap
between VBNC and persister states that are rarely
studied in the same context [4]. Specifically, in this
paper we quantitatively compare persister and VBNC
fractions in a stationary phase E. coli culture, and
characterize the size, morphology, and activity of se-
lected promoters in persister and VBNC cells exposed
to the same microenvironment. However, our ap-
proach could easily be adapted to measure other
physiological parameters previously linked to the for-
mation of VBNC and persister cells such as uptake
and efflux of nutrients and drugs [18, 39], metabolic
activity [5], and mRNA metabolism [40].
Little is known about the genetic control underlying
the VBNC state and the gene expression profile in
VBNC E. coli [3, 41, 42]. Indeed, transcriptome analysis
has been reported only for V. cholerae VBNC cells [43].
Furthermore, gene expression profiling is typically car-
ried out on VBNC cells isolated after exposure to drugs
[27] or other stressful environments such as cold sea-
water or low pH [3, 43], which affect the VBNC state
[44]. Our approach instead allows investigating VBNC
cells, alongside persister cells, before drug treatment and
in a microenvironment that we can accurately control
via microfluidics. In this respect, our approach is likely
to change the way we investigate non-growing subpopu-
lations within clonal or mixed microbial populations.
It is worth noting that, if VBNC cells are present in
microbiological quality control samples from the food
industry, water distribution systems, or hospitals, the
number of viable bacteria in the sample will be under-
estimated via the widely employed CFU count method.
Therefore, the inability to detect VBNC cells can pose
a risk to human health [3]. Our platform represents a
rapid and reliable tool to detect VBNC cells in bacter-
ial populations. This allowed us to unambiguously
demonstrate that VBNC cells are not in a transitory
stage in the degeneration of bacteria leading to cell
death [45, 46]. On the contrary, our data proves that,
even after drug treatment, at least the tolC promoter
remained active in VBNC cells and thus supports the
hypothesis that VBNC cells are in a transitional state
awaiting for suitable conditions to resuscitate [44]. In
this respect, our single-cell approach represents an
ideal tool for the future investigation of the mecha-
nisms underlying VBNC resuscitation, which remain
largely unknown [3, 47].
Our microfluidic system can be adapted to investigate
other bacterial pathogens and cell types, including can-
cer populations where drug-tolerant cells have been
identified [48]. More generally, our platform will allow
the investigation of how non-growing subpopulations
within clonal or mixed microbial populations respond to
changes in the environmental pH, temperature, and nu-
trient content. Furthermore, we are currently working
on scaling up our microfluidic system to investigate per-
sister and VBNC phenotypes occurring at frequencies
below 10-3. Specifically, we plan to apply our approach
to bacterial cultures transitioning from the exponential
to the stationary phase when the fraction of persister,
and possibly VBNC cells, monotonously increases from
10-5 to 10-2 [26], thus suggesting that the changes occur-
ring in the culture environment might favor the forma-
tion of these phenotypes. Such a higher throughput
system will also allow investigating candidate VBNC cell
formation mechanisms involving multiple genes through
the simultaneous investigation of several reporter strains
[4]. In this respect, a recent study investigated the ex-
pression of up to 100 genes in persister cells, but not in
VBNC cells, by using fluorescence-activated cell sorting,
sequencing, and a library of promoter reporters [33].
However, this approach also relies on the use of antibi-
otics to identify persister cells and does not allow mea-
surements of gene expression on the same cell before,
during, and after drug treatment.
Conclusion
There is currently a lack of biomarkers that can be used
to segregate VBNC cells from the majority of S cells before
antibiotic treatment [33]. Our single-cell approach allowed
us to establish that, when using the tnaC reporter strain,
stationary phase persister and VBNC E. coli were signifi-
cantly less fluorescent than susceptible E. coli and will allow
future identification of other genes that are differentially
regulated in VBNC cells before antibiotic treatment. The
associated reporter strains could be used to isolate natively
formed VBNC cells via fluorescence-activated cell sorting
for downstream transcriptomic and proteomic analysis. As
such, our novel single-cell approach provides a new oppor-
tunity to unravel the molecular mechanisms underlying the
capability of microbial pathogens to survive drug treatment
and remain non-growing.
Methods
Chemicals and cell culture
All chemicals were purchased from Fisher Scientific or
Sigma-Aldrich unless otherwise stated. LB medium
(10 g/L tryptone, 5 g/L yeast extract, and 10 g/L NaCl)
and LB agar plates (LB with 15 g/L agar) were used for
planktonic growth and enumeration of CFUs, respect-
ively. E. coli BW25113 were purchased from Dharmacon
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(GE Healthcare). tolC, tnaC, and ptsG reporter strains of
an E. coli K12 MG1655 promoter library [34] were pur-
chased from Dharmacon (GE Healthcare). Plasmids were
extracted and transformed into chemically competent E.
coli BW25113 as previously reported [33]. We verified
that these reporter strains exhibit similar growth rates
and levels of fP and fVBNC compared to wild-type E. coli
BW25113. Overnight cultures were prepared by picking
a single colony of E. coli BW25113 from a streak plate
and growing it in 200 mL fresh LB medium in a shaking
incubator at 200 rpm and 37 °C for 17 h.
Fabrication of the microfluidic devices
The mold for the mother machine microfluidic device
[24] was obtained by pouring epoxy onto a polydimeth-
ylsiloxane (PDMS, Dow Corning) replica of the original
mold containing 12 independent microfluidic chips
(kindly provided by S. Jun). Each of these chips is
equipped with approximately 6000 lateral microfluidic
channels with width and height of approximately 1 μm
each and a length of 25 μm. These lateral channels are
connected to a main microfluidic chamber that is 25 and
100 μm in height and width, respectively. PDMS replicas
of this device were realized as previously described [49].
Briefly, a 9:1 (base:curing agent) PDMS mixture was cast
on the mold and cured at 70 °C for 120 min in an oven.
The cured PDMS was peeled from the epoxy mold and
cut into individual chips. Fluidic accesses were created
by using a 0.75 mm biopsy punch (Harris Uni-Core,
WPI). The PDMS chip was irreversibly sealed on a glass
coverslip by exposing both surfaces to oxygen plasma
treatment (10 s exposure to 30 W plasma power, Plasma
etcher, Diener, Royal Oak, MI, USA). This treatment
temporarily rendered the PDMS and glass hydrophilic, so
within 5 min after bonding the chip was filled with 2 μL of
a 50 mg/mL bovine serum albumin solution and incubated
at 37 °C for 1 h, thus passivating the device’s internal
surfaces and preventing subsequent cell adhesion.
Microfluidics-microscopy assay to identify and study
VBNC cells
An overnight culture was prepared as described above.
Spent LB broth and bacteria were prepared by centrifu-
ging the overnight culture (10 min at 3000 g and 20 °C).
The supernatant was filtered twice (Medical Millex-GS
Filter, 0.22 μm, Millipore Corp.) and used to re-suspend
the bacteria in their spent LB to an optical density of 50
at 595 nm. Bovine serum albumin was added to the
bacterial suspension at a concentration of 0.5 mg/mL. A
2-μL aliquot of this suspension was injected in the above
described microfluidic device and incubated at 37 °C.
The high bacterial concentration favors bacteria entering
the narrow lateral channels from the main microcham-
ber of the mother machine (Fig. 1a, e) [24]. We found
that an incubation time of 20 min allowed filling of the
lateral channels with, typically, between one and three
bacteria per channel. An average of 60% of lateral chan-
nels of the mother machine device were filled with bac-
teria and 50% of the filled channels contained single
bacteria. This facilitated tracking each single bacterium
throughout the different phases of our assay (Fig. 1). The
microfluidic device was completed by the integration of
fluorinated ethylene propylene tubing (1/32" × 0.008").
The inlet tubing was connected to a flow-rate measuring
device (Flow Unit S, Fluigent, Paris, France) controlling
the pressure applied by a computerized pressure-based
flow control system (MFCS-4C, Fluigent) on the inlet res-
ervoir feeding the flow rate device itself. This instrumenta-
tion was controlled by MAESFLO software (Fluigent). At
the end of the 20 min incubation period, the chip was
mounted on an inverted microscope (IX73 Olympus,
Tokyo, Japan) and the bacteria remaining in the main
microchamber of the mother machine were washed into
the outlet tubing and reservoir by flowing spent LB at
300 μL/h for 8 minutes. At this point (Fig. 1a, e) we
acquired our first set of images in bright-field and fluores-
cence mode (the latter were acquired only when using
reporter strains). Images were collected via a 60×, 1.2 NA
objective (UPLSAPO60XW, Olympus) and a sCMOS
camera (Zyla 4.2, Andor, Belfast, UK). The region of inter-
est of the camera was adjusted to visualize 23 lateral chan-
nels per image. Upon acquiring each bright-field image
the microscope was switched to fluorescent mode and
FITC filter using custom built Labview software and a
fluorescence image was acquired by exposing the bacteria
to the blue excitation band of a broad-spectrum LED
(CoolLED pE300white, Andover, UK) at 100%, 20%, and
20% of its intensity and for 0.05, 0.03, and 0.05 s for tolC,
tnaC, and ptsG imaging, respectively. These parameters
were adjusted in order to maximize the signal to noise
ratio. The device was moved by two automated stages (M-
545.USC and P-545.3C7, Physik Instrumente, Karlsruhe,
Germany, for coarse and fine movements, respectively) to
image the next set of lateral channels and these steps were
repeated until approximately 2000 bacteria were imaged
(average of 1943 ± 316 bacteria per experiment). After
acquiring the first set of images, the microfluidic environ-
ment was changed by flowing LB containing ampicillin at
25× MIC at 300 μL/h for 8 minutes and then at 100 μL/h
for 3 h (t = 0, Fig. 1b). Imaging was carried out hourly
for 0 < t < 6 h and at t = 24 h. After 3 h, the antibiotic
was removed and LB medium was flowed in the chip at
300 μL/h for 8 minutes and then at 100 μL/h for 21 h
(Fig. 1c). Crucially, at t = 24 h live/dead staining [27]
was performed by flowing SYTO9 and propidium iod-
ide (PI, Thermo Fisher Scientific) into the microfluidic
device for 25 and 10 min, respectively, at a concentra-
tion of 3.34 and 30 μM, respectively, according to the
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manufacturer’s specifications. To the best of our know-
ledge, this is the first time that live/dead staining is im-
plemented in the mother machine approach and it is
crucial for distinguishing VBNC cells from susceptible
non-lysed cells. Indeed, these fluorescent dyes differ in
their ability to penetrate the bacterial membrane and
stain live and dead bacterial cells, respectively [50].
Bright-field and fluorescence images were acquired to
determine whether each bacterium was dead or alive.
SYTO9 and PI staining were imaged by using 60% blue
and 100% green LED intensity, FITC and TRITC filters,
respectively, and an exposure time of 0.01 s. PI only
was used imaging reporter strains. The entire assay was
carried out at room temperature.
Image and data analysis
Microfluidics confinement and time-lapse microscopy
allow the tracking of each individual bacterium and its
eventual progeny throughout the entire assay. All image
processing was performed using a custom Python mod-
ule [51]. Briefly, channels and bacteria were detected by
using automated thresholding algorithms. Each channel
within a frame and each bacterium within a channel
were assigned unique numeric labels. Each bacterium
was tracked by taking into account all of the possible
combinations for cell death or division and the most
likely calculated depending on several factors, including
each cell location and area. Once bacterial lineage was
established, the corresponding masks were used to ex-
tract information about each bacterium such as width,
length, area and fluorescence intensity from the corre-
sponding fluorescence image. The fluorescence back-
ground was determined as the average fluorescence for
the areas of the channels that did not contain bacteria
and subtracted from the fluorescence intensity measured
on each bacterium. For each bacterium, the measured
GFP signal was normalized by cell size to account for
variations in expression due to the cell cycle [52]. The
final output images showed each detected bacterium
with its unique numeric label. The measurements for all
bacteria within a frame across the different time points
were written to .csv files. The detection and label assign-
ment was visually verified and each bacterium classified
as persister, VBNC, susceptible lysed, or susceptible non-
lysed phenotype as defined in Fig. 1. Further details of
this framework will be reported in a separate publication
currently in preparation. Semi-automated measurements
were performed on randomly selected pools of images
using ImageJ and the accuracy of the above automated
framework verified. All data reported in GraphPad Prism
7 represent mean and standard error of the mean of at
least biological triplicates. Due to the large sample
sizes, error bars are small compared to the corre-
sponding mean values and are hidden behind the data
points in some of the graphs (Fig. 4d–f, Additional
file 1: Figure S1a, Additional file 3: Figure S3b, and
Additional file 4: Figure S4). Statistical significance
was tested by unpaired t test with Welch’s correction.
MIC determination and persister enumeration via CFU assay
The MIC of ampicillin against E. coli strain BW25113
was determined using a 96-well plate method. E. coli
was grown in LB medium for 17 h at varying concentra-
tions of ampicillin (0.5–512 μg mL-1) and the absorb-
ance measured at 595 nm. The MIC was defined as the
lowest concentration at which the absorbance was the
same as the control (bacteria-free LB) and determined as
5 μg mL-1. In order to measure the fraction of persister
cells to ampicillin in the culture, six 500-μL aliquots
were withdrawn from the overnight culture. Three were
used for untreated controls, centrifuged (12,000 g for
5 minutes), the supernatant removed, the pellet re-
suspended in phosphate-buffered saline, serially diluted,
plated on LB agar, and CFU counted after overnight
growth in an incubator at 30 °C. Three aliquots were
supplied with 500 μL LB containing ampicillin at 50 ×
MIC (resulting in a final concentration of 25 ×MIC) and
returned to the shaking incubator. After 3 h, these ali-
quots were centrifuged, the supernatant removed, the
pellet re-suspended in phosphate-buffered saline, serially
diluted, plated on LB agar, and CFU counted after over-
night growth in an incubator at 30 °C. The persister cell
fraction fP was defined as the number of CFUs obtained
from the treated aliquots divided by the number of CFUs
obtained from the untreated aliquots.
Additional files
Additional file 1: Figure S1. Bacterial growth in the microfluidic
device. a) Fractional distributions of time elapsed to first cell division for
persister cells. b) Fractional distributions of time elapsed to first cell
division for untreated cells in separate control experiments where LB but
without ampicillin was added in the mother machine device. n ≥ 3, nP =
134 and nC = 1274 persister and untreated control cells, respectively. c)
Corresponding average length of persister cells (circles) before (t = 0),
during (0 < t < 3 h), and after treatment (3 < t < 24 h) with ampicillin at a
concentration of 25 × MIC in LB and of untreated control cells
(diamonds). Data and error bars are mean and standard error of the
mean obtained by averaging single-cell values obtained on nP = 33 and
nC = 592 persister and untreated control cells, respectively, in biological
triplicate. We did not observe any significant differences between the
results obtained from different biological replica. Due to the large
sample sizes, error bars are small compared to the corresponding mean
values and are hidden behind some of the data points in (c). (PNG 1509 kb)
Additional file 2: Figure S2. Bulk and single-cell persister enumeration.
Dependence of the frequency of persister cells on ampicillin concentration
as measured via the single-cell microfluidics-microscopy assay (full circles)
illustrated in Fig. 1 and the colony forming unit assay (open circles). The two
assays are performed on aliquots withdrawn from the same E. coli overnight
culture. Data and error bars are mean and standard error of the mean of
measurements obtained in biological triplicate (N = 3). Data agreement
within experimental error confirms the validity of the newly developed
microfluidic assay. (PNG 226 kb)
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Additional file 3: Figure S3. Subgroups in the subpopulation of
susceptible cells. a) Distribution of GFP fluorescence levels in susceptible
cells of the tolC reporter strain after ampicillin treatment (t = 3 h). b)
Temporal dependence of average fluorescence levels for susceptible cells
that fluoresce (filled triangles) and do not fluoresce (open triangles) at t
= 3 h, resembling the two susceptible cells reported in Fig. 3. Data and
error bars are the mean and standard error of n = 623 (filled triangles)
and n = 754 (open triangles) susceptible cells measured in biological
triplicate (N = 3). We did not observe any significant difference between
the results obtained from different biological replica. Due to the large
sample sizes, error bars are small compared to the corresponding mean
values and are hidden behind the data points in (b). (PNG 365 kb)
Additional file 4: Figure S4. Viable but non-culturable (VBNC) cells are
different from susceptible non-lysed cells (SNL). Average pattern of GFP
fluorescence levels of the VBNC (green squares) and SNL (black triangles)
phenotypes throughout the microfluidic assay for the a) tolC, b) tnaC, and c)
ptsG reporter strains. The two phenotypes are already distinguishable during
drug treatment. Data and error bars are obtained as the mean and standard
error of the mean of single-cell measurements in biological triplicate (N = 3)
for each reporter strain for a total of nVBNC = 147 and nSNL = 335 VBNC
and SNL cells, respectively. We did not observe any significant
difference between the results obtained from different biological
replica. Due to the large sample sizes, error bars are small compared
to the corresponding mean values and are hidden behind some of
the data points. (PNG 568 kb)
Additional file 5: Figure S5. Susceptible cells are indistinguishable
from untreated cells before drug treatment. Distribution of fluorescence
levels in the susceptible phenotype before drug treatment (t = 0) and in
untreated control cells before regrowth in LB (t = 0) in the a) tolC, b)
tnaC, and c) ptsG reporter strain. The two populations are not statistically
different, an unpaired t test with Welch’s correction yielding a P value of
0.07, 0.7, and 0.9, respectively. The bottom and top of the box are the
first and third quartiles, the band inside the box is the median, the
bottom and top whiskers represent the 10th and 90th percentiles,
respectively. Data are obtained at least in biological triplicate (N = 3) for
each reporter strain employed for a total of nS = 6659 and nC = 3076
susceptible and control cells, respectively. We did not observe any
significant difference between the results obtained from different
biological replica. (PNG 423 kb)
Additional file 6: Figure S6. Persister and untreated control cells have
similar patterns of fluorescence levels during regrowth on LB. Average
pattern of fluorescence levels in persister (circles) and untreated control
(diamonds) cells throughout the microfluidic assay in the a) tolC, b) tnaC,
and c) ptsG reporter strains. Persister and untreated control cells exhibit
similar patterns of fluorescence levels during regrowth on LB (3 < t < 24 h
and 0 < t < 24 h for persister and control cells, respectively)
demonstrating that persister cells revert back to a normally growing state
after removal of the antibiotic drug. Data and error bars are obtained as
the mean and standard error of the mean of single-cell measurements in
biological triplicate (N = 3) for each reporter strain for a total of nP = 132
and nC = 3076 persister and control cells, respectively. We did not observe
any significant difference between the results obtained from different
biological replica. Due to the large sample sizes, error bars are small
compared to the corresponding mean values and are hidden behind the
data points. (PNG 585 kb)
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